Literature DB >> 33433580

Glaucoma in Adults-Screening, Diagnosis, and Management: A Review.

Joshua D Stein1,2,3, Anthony P Khawaja4, Jennifer S Weizer1.   

Abstract

Importance: Glaucoma is the most common cause of irreversible blindness worldwide. Many patients with glaucoma are asymptomatic early in the disease course. Primary care clinicians should know which patients to refer to an eye care professional for a complete eye examination to check for signs of glaucoma and to determine what systemic conditions or medications can increase a patient's risk of glaucoma. Open-angle and narrow-angle forms of glaucoma are reviewed, including a description of the pathophysiology, risk factors, screening, disease monitoring, and treatment options. Observations: Glaucoma is a chronic progressive optic neuropathy, characterized by damage to the optic nerve and retinal nerve fiber layer, that can lead to permanent loss of peripheral or central vision. Intraocular pressure is the only known modifiable risk factor. Other important risk factors include older age, nonwhite race, and a family history of glaucoma. Several systemic medical conditions and medications including corticosteroids, anticholinergics, certain antidepressants, and topiramate may predispose patients to glaucoma. There are 2 broad categories of glaucoma, open-angle and angle-closure glaucoma. Diagnostic testing to assess for glaucoma and to monitor for disease progression includes measurement of intraocular pressure, perimetry, and optical coherence tomography. Treatment of glaucoma involves lowering intraocular pressure. This can be achieved with various classes of glaucoma medications as well as laser and incisional surgical procedures. Conclusions and Relevance: Vision loss from glaucoma can be minimized by recognizing systemic conditions and medications that increase a patient's risk of glaucoma and referring high-risk patients for a complete ophthalmologic examination. Clinicians should ensure that patients remain adherent with taking glaucoma medications and should monitor for adverse events from medical or surgical interventions used to treat glaucoma.

Entities:  

Mesh:

Year:  2021        PMID: 33433580     DOI: 10.1001/jama.2020.21899

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  39 in total

1.  A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study.

Authors:  Julia Tau; María Silvia Passerini; Melina Del Papa; Alejandro Aguilar; Alejandro Berra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-11       Impact factor: 3.117

Review 2.  Application of advanced magnetic resonance imaging in glaucoma: a narrative review.

Authors:  Longdan Kang; Chao Wan
Journal:  Quant Imaging Med Surg       Date:  2022-03

3.  Cell atlas of the human ocular anterior segment: Tissue-specific and shared cell types.

Authors:  Tavé van Zyl; Wenjun Yan; Alexi M McAdams; Aboozar Monavarfeshani; Gregory S Hageman; Joshua R Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-15       Impact factor: 12.779

4.  Short-term outcomes of mitomycin C-augmented excisional bleb revision with capsulectomy for failed Ahmed glaucoma valve.

Authors:  Bar Davidov; Shimon Kurtz; Ilona Mohilevtseva; Michael Waisbourd; Rony Rachmiel
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

5.  Optical coherence tomography evaluation of retinal nerve fiber layer thickness in non-arteritic anterior ischemic optic neuropathy and primary open angle glaucoma: a systematic review and Meta-analysis.

Authors:  Yu-Xin Tong; Xin-Yu Zhang; Yi He; Zong-Lin Chen; Bing Jiang
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

Review 6.  Association Between Diabetes, Diabetic Retinopathy, and Glaucoma.

Authors:  Yangjiani Li; William Mitchell; Tobias Elze; Nazlee Zebardast
Journal:  Curr Diab Rep       Date:  2021-09-08       Impact factor: 5.430

Review 7.  A Review on Glaucoma Drainage Devices and its Complications.

Authors:  Sajal Gupta; Sandhya Jeria
Journal:  Cureus       Date:  2022-09-12

Review 8.  From Bench to Bed: The Current Genome Editing Therapies for Glaucoma.

Authors:  Meihui He; Rong Rong; Dan Ji; Xiaobo Xia
Journal:  Front Cell Dev Biol       Date:  2022-05-16

9.  Recent trends in glaucoma surgery: a nationwide database study in Japan, 2011-2019.

Authors:  Asahi Fujita; Yohei Hashimoto; Hiroki Matsui; Hideo Yasunaga; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2022-01-19       Impact factor: 2.447

10.  Diabetes Exacerbates the Intraocular Pressure-Independent Retinal Ganglion Cells Degeneration in the DBA/2J Model of Glaucoma.

Authors:  Rosario Amato; Francesca Lazzara; Tsung-Han Chou; Giovanni Luca Romano; Maurizio Cammalleri; Massimo Dal Monte; Giovanni Casini; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.